Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

21.32 -0.30 (-1.39%)
Streaming Delayed Price Updated: 10:16 AM EDT, Jun 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hims & Hers Health Inc

< Previous 1 2 3 4 5 Next >
3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers
These three stocks are looking to get a chunk of the total added jobs in the economy, meaning that analyst double-digit upside and growth projections are real 
Via MarketBeat
Topics Economy
Exposures Economy
MarketBeat Week in Review – 6/3 - 6/7
Equity markets shrugged off a much hotter-than-expected jobs report, but there could be more volatility after the next readings on inflation come out next week 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments 
Via MarketBeat
Hims & Hers Health Inc. (NYSE: HIMS) Near the Top of Equities by Percentage Gain on 2/27
Via Investor Brand Network
Call Option Volumes Spiked For These 3 Stocks
Option traders decided to plow into call contracts for these three stocks, investors can see the specific fundamental reasons behind this decision 
Via MarketBeat
LifeMD Can Surge on Its GLP-1 Offerings
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result 
Via MarketBeat
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
From Hims & Hers
Via Business Wire
Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
From Hims & Hers
Via Business Wire
3 Stocks That Suddenly Drew in Options Traders
Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside. 
Via MarketBeat
Hims & Hers Health Stock Could Become a Wealth Compounder
Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24 
Via MarketBeat
Topics Economy
Exposures Economy
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
From Hims & Hers Health, Inc.
Via Business Wire
3 Stocks With Unusual Call Option Activity
Three stocks reported rising call option buying activity could see even higher prices soon. Analysts see the writing on the wall, and traders stampeded in 
Via MarketBeat
Topics Economy
Exposures Interest Rates
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
Can WeightWatchers Regain its Mojo after Oprah Steps Down?
WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). 
Via MarketBeat
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Stock Rises On Stimulating Earnings Growth
Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience 
Via MarketBeat
bluebird bio stock is ripe for a 400% institutional short squeeze
Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From Hims & Hers Health, Inc.
Via Business Wire
This healthcare stock making a buzz with 160% growth
Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them. 
Via MarketBeat
Topics Economy
Exposures Economy
Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care
From Hims & Hers Health, Inc.
Via Business Wire
Weight Watchers gains from Oprah’s GLP-1 weight-loss
Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
LifeMD expands telehealth GLP-1weight-loss service with Medifast
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing 
Via MarketBeat
Ozempic vs. Mounjaro:: Battle of the bulge
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage 
Via MarketBeat
Exposures Product Safety
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers earnings highlight expanded personalized treatments
E-health and wellness platform operator Hims & Hers Inc. reported a stellar quarter of growth that highlighted its expanded line of personalized products 
Via MarketBeat
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
From Hims & Hers Health, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.